A novel enzyme may play a major role in anencephaly, offering hope for a genetic test or even therapy for the rare fatal birth defect in which the brain fails to develop, according to a study from researchers at the University of Illinois at Chicago College of Medicine. The study appears in the October issue of the journal of Molecular Endocrinology. In the U.S. ...
Anytime
